Chimeric Therapeutics, a clinical-stage cell therapy company and an Australian leader in cell therapy, has entered a partnership with Be The Match BioTherapies, an organization offering supply chain solutions for companies developing and commercializing cell and gene therapies. Be The Match BioTherapies provides end-to-end services designed to expedite collection, transport and delivery of cellular starting material and clinical drug product, which will support Chimeric’s expanded clinical de...